Related Experiment Video
Updated: May 15, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Advances in endovascular repair for type A aortic dissection
Kewei Wang1,2, Peng Jiang1,2, Yongpan Cui1,2
1Department of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Journal of Cardiothoracic Surgery
|May 14, 2026
Summary
Endovascular repair for Type A Aortic Dissection (TAAD) shows promise but faces challenges. Further research is needed to develop standardized devices and validate safety and efficacy for this complex condition.
Area of Science:
- Cardiovascular Surgery
- Medical Device Technology
- Aortic Disease Research
Background:
- Type A Aortic Dissection (TAAD) presents high mortality and limitations with current open surgical and hybrid repair methods.
- Endovascular repair offers a potential alternative but requires further investigation.
Purpose of the Study:
- To review the current status and advancements in endovascular repair for TAAD.
- To assess the feasibility, techniques, and outcomes of endovascular approaches for TAAD.
Main Methods:
- Comprehensive literature review on anatomical feasibility of stent grafts for TAAD.
- Analysis of various endovascular repair procedures, including aortic valve, ascending aorta, and aortic arch repair techniques.
- Evaluation of advantages, disadvantages, success rates, and complications of endovascular repair.
Main Results:
- Commercial stent graft feasibility for TAAD is low (4%-21%), but combined stent-valve approaches show higher applicability (80%).
- Modular Endo-Bentall stent grafts demonstrate 66.4% feasibility for coronary artery reconstruction.
- Aortic arch repair techniques exhibit high technical success rates (84%-100%) with variable complication rates (0%-18%).
Conclusions:
- Endovascular repair for TAAD is complex, with a lack of standardized, commercially available devices.
- Extensive clinical studies are essential to validate the safety and efficacy of endovascular solutions for TAAD.
- Optimized endovascular strategies are needed to improve outcomes for TAAD patients.